Inspired by the brain's structure, we have developed an efficient, scalable, and flexible non-von Neumann architecture that leverages contemporary silicon technology. To demonstrate, we built a 5.4-billion-transistor chip with 4096 neurosynaptic cores interconnected via an intrachip network that integrates 1 million programmable spiking neurons and 256 million configurable synapses. Chips can be tiled in two dimensions via an interchip communication interface, seamlessly scaling the architecture to a cortexlike sheet of arbitrary size. The architecture is well suited to many applications that use complex neural networks in real time, for example, multiobject detection and classification. With 400-pixel-by-240-pixel video input at 30 frames per second, the chip consumes 63 milliwatts.
We survey the current state of phase change memory (PCM), a non-volatile
solid-state memory technology built around the large electrical contrast
between the highly-resistive amorphous and highly-conductive crystalline states
in so-called phase change materials. PCM technology has made rapid progress in
a short time, having passed older technologies in terms of both sophisticated
demonstrations of scaling to small device dimensions, as well as integrated
large-array demonstrators with impressive retention, endurance, performance and
yield characteristics.
We introduce the physics behind PCM technology, assess how its
characteristics match up with various potential applications across the
memory-storage hierarchy, and discuss its strengths including scalability and
rapid switching speed. We then address challenges for the technology, including
the design of PCM cells for low RESET current, the need to control
device-to-device variability, and undesirable changes in the phase change
material that can be induced by the fabrication procedure. We then turn to
issues related to operation of PCM devices, including retention,
device-to-device thermal crosstalk, endurance, and bias-polarity effects.
Several factors that can be expected to enhance PCM in the future are
addressed, including Multi-Level Cell technology for PCM (which offers higher
density through the use of intermediate resistance states), the role of coding,
and possible routes to an ultra-high density PCM technology.Comment: Review articl
T cells react to extremely small numbers of activating agonist peptides. Spatial organization of T-cell receptors (TCR) and their peptide-major histocompatibility complex (pMHC) ligands into microclusters is correlated with T-cell activation. Here we have designed an experimental strategy that enables control over the number of agonist peptides per TCR cluster, without altering the total number engaged by the cell. Supported membranes, partitioned with grids of barriers to lateral mobility, provide an effective way of limiting the total number of pMHC ligands that may be assembled within a single TCR cluster. Observations directly reveal that restriction of pMHC content within individual TCR clusters can decrease T-cell sensitivity for triggering initial calcium flux at fixed total pMHC density. Further analysis suggests that triggering thresholds are determined by the number of activating ligands available to individual TCR clusters, not by the total number encountered by the cell. Results from a series of experiments in which the overall agonist density and the maximum number of agonist per TCR cluster are independently varied in primary T cells indicate that the most probable minimal triggering unit for calcium signaling is at least four pMHC in a single cluster for this system. This threshold is unchanged by inclusion of coagonist pMHC, but costimulation of CD28 by CD80 can modulate the threshold lower.cell biophysics | cell patterning | immune synapse
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.